NO920161D0 - Stabile vaksineblandinger inneholdende interleukiner - Google Patents

Stabile vaksineblandinger inneholdende interleukiner

Info

Publication number
NO920161D0
NO920161D0 NO1992920161A NO920161A NO920161D0 NO 920161 D0 NO920161 D0 NO 920161D0 NO 1992920161 A NO1992920161 A NO 1992920161A NO 920161 A NO920161 A NO 920161A NO 920161 D0 NO920161 D0 NO 920161D0
Authority
NO
Norway
Prior art keywords
interleukines
mixtures containing
interleukin
mineral
stable vaccine
Prior art date
Application number
NO1992920161A
Other languages
English (en)
Other versions
NO920161L (no
NO301577B1 (no
Inventor
Subramonia Pillai
Garvin Bixler
Original Assignee
Praxis Biolog Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Praxis Biolog Inc filed Critical Praxis Biolog Inc
Publication of NO920161D0 publication Critical patent/NO920161D0/no
Publication of NO920161L publication Critical patent/NO920161L/no
Publication of NO301577B1 publication Critical patent/NO301577B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505—Inorganic adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55522—Cytokines; Lymphokines; Interferons
    • A61K2039/55527—Interleukins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Virology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO920161A 1989-07-14 1992-01-13 Fremgangsmåte for fremstilling av en stabil vaksineblanding og fremgangsmåte for stabilisering av interleukin i en vaksineblanding NO301577B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US37974289A 1989-07-14 1989-07-14
PCT/US1990/003982 WO1991001143A1 (en) 1989-07-14 1990-07-16 Stable vaccine compositions containing interleukins

Publications (3)

Publication Number Publication Date
NO920161D0 true NO920161D0 (no) 1992-01-13
NO920161L NO920161L (no) 1992-03-05
NO301577B1 NO301577B1 (no) 1997-11-17

Family

ID=23498494

Family Applications (1)

Application Number Title Priority Date Filing Date
NO920161A NO301577B1 (no) 1989-07-14 1992-01-13 Fremgangsmåte for fremstilling av en stabil vaksineblanding og fremgangsmåte for stabilisering av interleukin i en vaksineblanding

Country Status (12)

Country Link
EP (1) EP0482076B1 (no)
JP (2) JP3485184B2 (no)
KR (1) KR0177179B1 (no)
AT (1) ATE121629T1 (no)
AU (1) AU648509B2 (no)
CA (1) CA2063587C (no)
DE (1) DE69018990T2 (no)
DK (1) DK0482076T3 (no)
ES (1) ES2075900T3 (no)
FI (1) FI104233B1 (no)
NO (1) NO301577B1 (no)
WO (1) WO1991001143A1 (no)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6406696B1 (en) 1989-10-27 2002-06-18 Tolerance Therapeutics, Inc. Methods of stimulating the immune system with anti-CD3 antibodies
DE69032484T4 (de) * 1989-10-27 1999-09-16 Arch Dev Corp Zusammensetzungen und deren verwendung zur förderung der immunopotentiation
GR1000881B (el) * 1990-08-06 1993-03-16 Praxis Biolog Inc Σταθερες συνθεσεις εμβολιου που περιεχουν ιντερλευκινες.
DK0563254T3 (da) * 1990-12-19 1996-02-12 Schering Corp Anvendelse af IL-4 til forstærkning af immunrespons på immunogener i vacciner
EP0584212A4 (en) * 1991-05-13 1994-11-30 Univ California LIPOSOMAL POLYSACCHARID VACCINE.
DE4126983A1 (de) * 1991-08-15 1993-02-18 Boehringer Mannheim Gmbh Verfahren zur herstellung von humanprotein-enthaltenden, konservierten arzneimitteln fuer infusions- oder injektionszwecke
DE69310182T2 (de) * 1992-08-10 1997-12-04 Us Gov Health & Human Serv Interleukin-4 stimulierter t-lymphozyten-zelltod
ZA936095B (en) * 1992-08-21 1994-03-14 Univ Melbourne Cytokine applications.
US6491916B1 (en) 1994-06-01 2002-12-10 Tolerance Therapeutics, Inc. Methods and materials for modulation of the immunosuppresive activity and toxicity of monoclonal antibodies
AU3541495A (en) * 1994-09-01 1996-03-22 Wisconsin Alumni Research Foundation Therapeutic remodeling in aids
US6509313B1 (en) 1996-02-28 2003-01-21 Cornell Research Foundation, Inc. Stimulation of immune response with low doses of cytokines
ATE325621T1 (de) * 1996-05-31 2006-06-15 Nat Univ Ireland Maynooth Il-12 als adjuvanz für bordetella pertussis impfstoffe
TW586934B (en) * 1997-05-19 2004-05-11 Sumitomo Pharma Immunopotentiating composition
US6270758B1 (en) 1998-10-08 2001-08-07 Duke University Substantially non-toxic biologically active mucosal adjuvants in vertebrate subjects
US6027731A (en) * 1998-11-17 2000-02-22 Wisconsin Alumni Research Foundation Pertussis toxin induced lymphocytosis
IT1302534B1 (it) 1998-12-21 2000-09-05 Fidia Advanced Biopolymers Srl Composizioni iniettabili, biocompatibili e biodegradabili comprendentialmeno un derivato dell'acido ialuronico, cellule condrogeniche, per
SK782002A3 (en) * 1999-07-21 2003-08-05 Lexigen Pharm Corp FC fusion proteins for enhancing the immunogenicity of protein and peptide antigens
US6656462B2 (en) 1999-12-03 2003-12-02 Richard S. Dondero Interleukin-1 muteins useful as vaccine adjuvants
SG10201504917PA (en) 2005-07-11 2015-07-30 Macrogenics Inc Methods For The Treatment Of Autoimmune Disorders Using Immunosuppressive Monoclonal Antibodies With Reduced Toxicity
EP1928419A1 (en) 2005-09-30 2008-06-11 Lipoxen Technologies Limited Multivalent liposomal vaccine compositions comprising polysaccharide antigens and a protein adjuvant
EP2037961B1 (en) 2006-06-14 2015-11-11 MacroGenics, Inc. Methods for the treatment of autoimmune disorders using monoclonal antibodies with reduced toxicity
JP2010520874A (ja) * 2007-03-09 2010-06-17 メルク・シャープ・エンド・ドーム・コーポレイション パピローマウイルスワクチン組成物
US10639367B2 (en) * 2012-11-02 2020-05-05 Cytuvax Composition comprising cytokine macro-aggregates
JOP20190242A1 (ar) * 2018-10-12 2020-04-12 Serum Institute Of India Pvt Ltd تركيبة لقاح توليفي تشمل فيروس شلل الأطفال ذو جرعة مخفّضة خاملة التنشيط وطريقة لتحضيرها
US20220008515A1 (en) 2018-11-16 2022-01-13 Neoimmunetech, Inc. Method of treating a tumor with a combination of il-7 protein and an immune checkpoint inhibitor
JP2023512456A (ja) 2020-01-13 2023-03-27 ネオイミューンテック， インコーポレイテッド Ｉｌ－７タンパク質と二重特異性抗体の組み合わせで腫瘍を治療する方法
WO2021158783A1 (en) 2020-02-05 2021-08-12 Washington University Method of treating a solid tumor with a combination of an il-7 protein and car-bearing immune cells
EP4232070A1 (en) 2020-10-26 2023-08-30 NeoImmuneTech, Inc. Methods of inducing stem cell mobilization
WO2022094475A1 (en) 2020-11-02 2022-05-05 Neoimmunetech, Inc. Use of interleukin-7 for the treatment of coronavirus
EP4240408A1 (en) 2020-11-05 2023-09-13 Neoimmunetech, Inc. Method of treating a tumor with a combination of an il-7 protein and a nucleotide vaccine
WO2023130081A1 (en) 2021-12-30 2023-07-06 Neoimmunetech, Inc. Method of treating a tumor with a combination of il-7 protein and vegf antagonist

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2849632B2 (ja) * 1988-04-08 1999-01-20 社団法人北里研究所 ワクチン製剤
DE3818054C2 (de) * 1988-05-27 1994-02-17 Biotest Pharma Gmbh Verwendung einer Kombination aus einem Antigen bzw. einer Vakzine und humanem Interleukin zur Behandlung der Non-Responsiveness gegenüber immunologischen Defektzuständen
JPH0236129A (ja) * 1988-07-22 1990-02-06 Ajinomoto Co Inc ワクチン効果増強剤

Also Published As

Publication number Publication date
EP0482076B1 (en) 1995-04-26
KR0177179B1 (ko) 1999-03-20
JP2004002463A (ja) 2004-01-08
DE69018990T2 (de) 1995-12-14
AU648509B2 (en) 1994-04-28
NO920161L (no) 1992-03-05
AU6050090A (en) 1991-02-22
KR920703103A (ko) 1992-12-17
CA2063587A1 (en) 1991-01-15
NO301577B1 (no) 1997-11-17
FI104233B (fi) 1999-12-15
CA2063587C (en) 2005-08-30
WO1991001143A1 (en) 1991-02-07
ES2075900T3 (es) 1995-10-16
DK0482076T3 (da) 1995-07-17
ATE121629T1 (de) 1995-05-15
JPH04506663A (ja) 1992-11-19
EP0482076A1 (en) 1992-04-29
FI920132A0 (fi) 1992-01-13
FI104233B1 (fi) 1999-12-15
JP3485184B2 (ja) 2004-01-13
DE69018990D1 (de) 1995-06-01

Similar Documents

Publication Publication Date Title
NO920161D0 (no) Stabile vaksineblandinger inneholdende interleukiner
FI945483A (fi) Hepatiitti B - pinta-antigeenejä ja muita antigeenejä sisältäviä yhdistelmärokotteita
IT8322155A0 (it) Procedimento per immobilizzare materie biologiche e composto di materie biologiche adsorbite in vermiculite.
ATE108668T1 (de) Transdermale applikation von 2-amino-6-n- propylamino-4,5,6,7-tetrahydrobenzothiazol.
ES2092306T3 (es) Adyuvante para vacunas.
GB8403921D0 (en) Preparation of lyophilized adsorbed polyvalent vaccines
ATE61937T1 (de) Antigenische zubereitungen und isolierung von solchen zubereitungen.
ES2111031T3 (es) Uso de preparaciones que contienen anticuerpos para la inmunosupresion.
SE8404707D0 (sv) Komposition innehallande pyridinlosligt extrakt och raffinerat detoxifierat endotoxin samt anvendning derav
IT8048567A0 (it) Isolatore antiurto e vibrazione
EA199900069A1 (ru) Вакцинная композиция против малярии
HK1014658A1 (en) Anti-idiotypic antibody which induces an immune response against a glycosphingolipid and use thereof
DE3485638D1 (de) Zubereitung von nitroestern fuer die koronartherapie.
DK1053017T3 (da) Vacciner omfattende interleukin-12 og herpes simplex virusantigen
IT1140561B (it) Dispositivo sollevatore particolarmente per lo spostamento di pianali di mobili e simili
ES2021732B3 (es) Procedimiento y dispositivo de tratamiento de fluidos que contienen particulas en suspension.
DK509485D0 (da) Toerstof til fremstilling af stabile suspensioner indeholdende 4-hydroxy- eller 4-acyloxy-4-androsten-3,17-dioner samt dets fremstilling og anvendelse
DE69032787T2 (de) Mutantes pseudorabiesvirus und dasselbe enthaltende vakzine
ES2056378T3 (es) Procedimiento de extraccion.
DE3885269T2 (de) Schwingungsdämpfer und Isolator.
GR1000881B (el) Σταθερες συνθεσεις εμβολιου που περιεχουν ιντερλευκινες.
IT9019907A0 (it) Dispositivo di sospensione di paia di scarpe e simili
FR2642267B3 (fr) Dispositif electro-osmotique utilise contre la desertification des sols
ES2077905T3 (es) Polipeptidos especificos de schizosaccharomyces.
IT8522253V0 (it) Dispositivo per l'uso degli aspiratori di polvere e liquidi anche come lavamoquettes e simili.